KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 146 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 3.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20 | -25.9% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $27 | -53.4% | 15,000 | 0.0% | 0.00% | -66.7% |
| Q1 2023 | $58 | -65.9% | 15,000 | +175.2% | 0.00% | -66.7% |
| Q4 2022 | $170 | -99.9% | 5,450 | 0.0% | 0.01% | -43.8% |
| Q3 2022 | $274,000 | +21.2% | 5,450 | 0.0% | 0.02% | +33.3% |
| Q2 2022 | $226,000 | -38.6% | 5,450 | 0.0% | 0.01% | -25.0% |
| Q1 2022 | $368,000 | +161.0% | 5,450 | +2377.3% | 0.02% | +220.0% |
| Q4 2021 | $141,000 | -66.3% | 220 | -99.6% | 0.01% | -73.7% |
| Q3 2021 | $419,000 | +35.2% | 50,220 | +151.1% | 0.02% | +11.8% |
| Q4 2020 | $310,000 | +6.2% | 20,000 | 0.0% | 0.02% | -10.5% |
| Q3 2020 | $292,000 | – | 20,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
| Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
| Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
| Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
| Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
| AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
| Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
| Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
| Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |